CYP2C19 genotypes in Germany and influence on treatment of Helicobacter pylori infection

被引：2
作者：
Kirsch, C
Schneider-Brachert, W
Grossmann, D
Stolte, M
Lehn, N
Miehlke, S
机构：
来源：
GASTROENTEROLOGY | 2003年 / 124卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(03)80897-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A180 / A180
页数：1
相关论文
共 50 条
  • [1] CYP2C19 genotypes and Helicobacter pylori eradication
    Sheu, Bor-Shyang
    Fock, Kwong-Ming
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 (08) : 1163 - 1163
  • [2] The impact of CYP2C19 genotypes on levofloxacin-based rescue therapy for Helicobacter pylori infection
    Shih, H. Y.
    Kuo, C. H.
    Wang, S. S. W.
    Chen, H. H.
    Wu, J. Y.
    Hsu, P. I.
    Wang, W. M.
    Jan, C. M.
    Wu, I. C.
    Chen, C. H.
    Lai, C. H.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A2 - A2
  • [3] Influence of CYP2C19 functional polymorphism on Helicobacter pylori eradication
    Ozdil, Burhan
    Akkiz, Hikmet
    Bayram, Suleyman
    Bekar, Aynur
    Akgollu, Ersin
    Sandikci, Macit
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2010, 21 (01) : 23 - 28
  • [4] CYP2C19 GENOTYPES AND FUTURE APPLICATIONS IN PERSONALIZED THERAPIES FOR HELICOBACTER PYLORI ERADICATION
    Arevalo, A.
    Trespalacios, A.
    Otero, W.
    Mercado, M.
    HELICOBACTER, 2014, 19 : 94 - 94
  • [5] CYP2C19 genotype-related efficacy of omeprazole for the treatment of infection caused by Helicobacter pylori
    Tanigawara, Y
    Aoyama, N
    Kita, T
    Shirakawa, K
    Komada, F
    Kasuga, M
    Okumura, K
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 66 (05) : 528 - 534
  • [6] CYP2C19 genotypes in the pharmacokinetics/pharmacodynamics of proton pump inhibitor-based therapy of Helicobacter pylori infection
    Yang, Jyh-Chin
    Lin, Chun-Jung
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2010, 6 (01) : 29 - 41
  • [7] Should the presence of polymorphisms of CYP2C19 enzymes influence the choice of the proton pump inhibitor for treatment of Helicobacter pylori infection?
    van Zanten, Sander Veldhuyzen
    Thompson, Kara
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (07) : 1476 - 1478
  • [8] Helicobacter pylori eradication, CYP2C19 and omeprazole doses
    Manes, G
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 22 (03) : 273 - 274
  • [9] CYP2C19 polymorphism influences Helicobacter pylori eradication
    Chao-Hung Kuo
    Chien-Yu Lu
    Hsiang-Yao Shih
    Chung-Jung Liu
    Meng-Chieh Wu
    Huang-Ming Hu
    Wen-Hung Hsu
    Fang-Jung Yu
    Deng-Chyang Wu
    Fu-Chen Kuo
    World Journal of Gastroenterology, 2014, 20 (43) : 16029 - 16036
  • [10] CYP2C19 polymorphism influences Helicobacter pylori eradication
    Kuo, Chao-Hung
    Lu, Chien-Yu
    Shih, Hsiang-Yao
    Liu, Chung-Jung
    Wu, Meng-Chieh
    Hu, Huang-Ming
    Hsu, Wen-Hung
    Yu, Fang-Jung
    Wu, Deng-Chyang
    Kuo, Fu-Chen
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (43) : 16029 - 16036
12345